Asia’s Protein Buyers Still Trail Global Best Practice — But Momentum is Building, New ARE Benchmark Finds

SINGAPORE, Feb 19, 2026 - (ACN Newswire via SeaPRwire.com) - Asia’s largest food retailers, manufacturers, restaurant chains, and hospitality groups remain behind international better practice on sustainable and responsible protein sourcing, but progress is accelerating across the region, according to The Asian Protein Buyers 100: An Assessment of Responsible and…

MHI Machinery Systems Participates in Ramp Merging Support Demonstration Experiment for Autonomous Vehicles on the Tokyo Metropolitan Expressway

TOKYO, Feb 18, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Machinery Systems, Ltd. (MHI-MS), a part of Mitsubishi Heavy Industries (MHI) Group, has concluded a joint research agreement with Tokyo's Metropolitan Expressway Co., Ltd. for a demonstration experiment of ramp merging support technology for autonomous vehicles.(1)The joint…

Bioxytran, Inc. Announces Commercial Distribution Agreement with Khoury Medical LTD for A-SUQAR Dietary Supplement

BOSTON, MA, Feb 17, 2026 - (ACN Newswire via SeaPRwire.com) - Bioxytran, Inc. (OTCMKTS: BIXT) (“Bioxytran” or the “Company”), a biotechnology company developing galectin-targeting carbohydrate technologies with applications across infectious disease, metabolic health, and inflammation, today announced that it has entered into a commercial Distribution Agreement with Khoury Medical LTD…

Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Novel Orexin Receptor Agonist E2086 for Narcolepsy

TOKYO, Feb 16, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has received an orphan drug designation for its in-house discovered and developed novel selective orexin 2 receptor agonist E2086, with prospective indication for narcolepsy, from the Ministry…